Novartis | NOVN - EPS Earnings Per Share


Novartis reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.99 2.28 Apr/28
FY2025Q4 Dec/2025 2.03 1.98 Apr/02
FY2025Q3 Sep/2025 2.04 1.58 Oct/28
FY2025Q2 Jun/2025 2.42 1.97 Jul/17
FY2025Q1 Mar/2025 2.28 1.80 Apr/29




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alcon AG USD 0.85 0.07 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Fresenius EUR 0.82 0.04 Mar/2026
Fresenius Medical Care EUR 0.91 0.53 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Orion EUR 0.66 1.19 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Philips EUR 0.23 0.37 Mar/2026
Recordati EUR 0.73 0 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025